Hospital operator HCA Healthcare (NYSE: HCA) will be reporting earnings this Friday before the bell. Here’s what to expect.

HCA Healthcare beat analysts’ revenue expectations by 0.5% last quarter, reporting revenues of $18.32 billion, up 5.7% year on year. It was a mixed quarter for the company, with an impressive beat of analysts’ EPS estimates but a slight miss of analysts’ same-store sales estimates.

Is HCA Healthcare a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting HCA Healthcare’s revenue to grow 5.6% year on year to $18.47 billion, slowing from the 10.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $6.32 per share.

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. HCA Healthcare has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1.9% on average.

Looking at HCA Healthcare’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Tenet Healthcare delivered year-on-year revenue growth of 3.3%, beating analysts’ expectations by 2.3%, and Quest reported revenues up 15.2%, topping estimates by 1.4%. Tenet Healthcare traded down 9.4% following the results while Quest was up 2.3%.

Read our full analysis of Tenet Healthcare’s results here and Quest’s results here.

Investors in the healthcare providers & services segment have had steady hands going into earnings, with share prices flat over the last month. HCA Healthcare is down 6% during the same time and is heading into earnings with an average analyst price target of $391.54 (compared to the current share price of $356.42).

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.